Entry Detail



General Information

Database ID:exR0266853
RNA Name:hsa-miR-206
RNA Type:miRNA
Chromosome:chr6
Starnd:+
Coordinate:
Start Site(bp):52144401End Site(bp):52144422
External Links:hsa-miR-206



Disease Information

Disease Name:Cystic Fibrosis
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D003550
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fibrosis, Cystic//Mucoviscidosis//Pulmonary Cystic Fibrosis//Cystic Fibrosis, Pulmonary//Pancreatic Cystic Fibrosis//Cystic Fibrosis, Pancreatic//Fibrocystic Disease of Pancreas//Pancreas Fibrocystic Disease//Pancreas Fibrocystic Diseases//Cystic Fibrosis of Pancreas



Expression Detail

GEO ID:GSE135119
Description:Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis
Experimental Design:Disease vs Control
Case Disease Type:Cystic Fibrosis
Case Disease SubType:NA
Case Sample:Cystic Fibrosis
Control Sample:Healthy
Number of Case:5
Number of Control:5
Number of Samples:10





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CAPNS1
chr19
36139953
36150353
+
NPEPPS
chr17
47522942
47623276
+
SPRED1
chr15
38252836
38357249
+
SLC30A7
chr1
100896076
100981757
+
DDX5
chr17
64498254
64508199
-
TRIM2
chr4
153152342
153339317
+
DLG3
chrX
70444835
70505490
+
LASP1
chr17
38869859
38921770
+
RTL8B
chrX
135020513
135022542
-
FOXP1
chr3
70952817
71583993
-
SDCBP
chr8
58552924
58582859
+
NME1-NME2
chr17
51153590
51171744
+
NR2C2
chr3
14947584
15053600
+
TNRC6B
chr22
40044817
40335808
+
CREB3L2
chr7
137874979
138002086
-
NETO2
chr16
47077703
47143945
-
ZNF518A
chr10
96129715
96205288
+
PGM2
chr4
37826660
37862937
+
PRR12
chr19
49591182
49626439
+
PTBP1
chr19
797075
812327
+
CALM1
chr14
90396502
90408268
+
NME2
chr17
51165435
51171747
+
AP1S1
chr7
101154456
101161596
+
MAPK1
chr22
21754500
21867680
-
GID4
chr17
18039408
18068405
+
SMCO4
chr11
93478472
93543391
-
SS18
chr18
26016253
26091217
-
CWC15
chr11
94962620
94973586
-
WIPF2
chr17
40219304
40284136
+
WDR5
chr9
134135365
134159968
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000816
chr17
80521229
80526077
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005332.7
chr17
68188547
68189165
+
AC145207.5
chr17
81878425
81881106
-
LINC00641
chr14
21200079
21206900
-
MALAT1
chr11
65497688
65506516
+
MIR4435-2HG
chr2
111006015
111523376
-
NEAT1
chr11
65422774
65445540
+
RMRP
chr9
35657751
35658018
-
Display:



Experiment Detail

GEO ID:GSE135119
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL19117
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2346
Sample treatment protocol:NA
RNA Extract protocol:Frozen samples; Mixture with Trizol Reagent followed by extraction with RNA Clean and Concentrator kit.
RNA library preparation protocol:Using the Affymetrix GeneChip miRNA 4.0 array, 8ul of plasma from each sample was labelled using FlashTag Biotin RNA Labelling kit.



Reference

PMID:31664087
Title:Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis
Author:Ideozu JE, Zhang X, Rangaraj V, McColley S, Levy H
Journal:Sci Rep. 2019 Oct 29;9(1):15483.
Description:we employed microarray technology to identify aberrantly expressed plasma ECmiRNAs in CF and elucidate the functional relevance of their targets.